Navigation Links
Tandem Diabetes Care Names Lonnie Smith As Chairman Of The Board
Date:2/20/2013

SAN DIEGO, Feb. 20, 2013 /PRNewswire/ -- Tandem Diabetes Care, Inc. ("Tandem") today announced the appointment of Lonnie Smith as Chairman of its Board of Directors.  Mr. Smith is Chairman of the Board and former chief executive officer of Intuitive Surgical.  He succeeds Dick Allen , who will continue as a member of the Board.

"Lonnie is an ideal Board leader for the Company at this exciting juncture in our evolution," said Dick Allen . "I am confident that with Lonnie's strategic guidance, the very successful operating experience of our CEO, Kim Blickenstaff , and the talents of our committed employees, we will significantly expand our commercial capabilities to get the t:slim Insulin Pump and our future products in the hands of people in the diabetes community who can benefit from them most."

"I am honored to be named Chairman and am committed to maximizing the opportunities we have at Tandem," said Lonnie Smith .  "The t:slim Insulin Pump is an exciting product, and I believe Tandem's development pipeline includes technology that will change the face of infusion therapy for people with diabetes."

Lonnie Smith 's career in the medical device industry spans more than four decades.  Mr. Smith is Chairman of the Board and an executive officer of Intuitive Surgical, where he previously served as chief executive officer from May 1997 to January 1, 2010.  Prior to joining Intuitive Surgical, Mr. Smith was senior executive vice president for Hillenbrand Industries, and he has also held positions with The Boston Consulting Group and IBM Corporation. Mr. Smith received his MBA from Harvard Business School and a BS in Electrical Engineering from Utah State University.

About Tandem Diabetes Care, Inc.  

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a privately held company dedicated to advancing the management of diabetes through novel technologies. The Company offers a comprehensive, user-centric and integrated approach to product design, development, and customer care. Tandem Diabetes Care is based in San Diego, Calif.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslim.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetesCorp.

t:slim and Tandem Diabetes Care are registered trademarks of Tandem Diabetes Care, Inc.


'/>"/>
SOURCE Tandem Diabetes Care, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tandem Diabetes Care Acquires Select Patents and Patent Applications from Smiths Medical
2. Data Related to Chimerixs Antiviral CMX001 to be Presented in Three Poster Sessions at the BMT Tandem Meetings
3. Data Demonstrating the Safety and Efficacy of Chimerixs Antiviral CMX001 Presented at BMT Tandem Meetings
4. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
5. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
6. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
7. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
8. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
9. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
10. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
11. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Feb. 22, 2017 Summary ... partnering deals and agreements entered into by the ... report: http://www.reportlinker.com/p03605669-summary/view-report.html Description The Global ... report provides understanding and access to partnering deals ... healthcare companies. - Trends in partnering ...
(Date:2/22/2017)... -- General Report Contents - Market Analyses include: ... - Market Drivers & Limiters for each chapter ... - Section on recent mergers & acquisitions ... This market comprises three product segments ... fiber-delivered lasers and direct delivery lasers. Products that ...
(Date:2/22/2017)... Calif., Feb. 22, 2017  Ultra Clean Holdings, ... of critical systems and subsystems for the semiconductor ... industries, today reported its financial results for the ... 2016. "2016 was a year of ... revenue reached record highs and together with continued ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... , ... Curemark, LLC announced today that the Blüm Study, a Phase 3 ... with Autism, is now enrolling at three new sites. These new sites are in ... , “There are currently no approved drugs that address the core symptoms of autism,” ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... athletics. It’s enough to overwork even the sharpest brain. , Power On, a ... healthy activity without over clocking the brain. Each capsule contains Cognizin® Citicoline, a ...
(Date:2/22/2017)... ... February 22, 2017 , ... The National Academy of ... with the April 2017 testing period. NACCM, a nonprofit organization, has provided the ... (CMC) exam is periodically re-calibrated to ensure that newly certified professionals are prepared ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... just as effective on smaller and sometimes harder to reach ones, according to ... presented at the International Stroke Conference in Houston by Ricardo A. Hanel, MD, ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... celebrated throughout the country today, as organizations, advocates, and individuals join together to ... and treatment access to ultimately save lives. , “Today we mark a nationwide ...
Breaking Medicine News(10 mins):